![A position statement on screening and management of prediabetes in adults in primary care in Australia - ScienceDirect A position statement on screening and management of prediabetes in adults in primary care in Australia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168822720304381-gr1.jpg)
A position statement on screening and management of prediabetes in adults in primary care in Australia - ScienceDirect
![The rise of childhood insulin resistance: should HbA1c be used for type 2 diabetes diagnosis in the young? - DiabetesontheNet The rise of childhood insulin resistance: should HbA1c be used for type 2 diabetes diagnosis in the young? - DiabetesontheNet](https://diabetesonthenet.com/wp-content/uploads/imagesmol/dotngmdDPC_22-3_Maarouf_Table2.png)
The rise of childhood insulin resistance: should HbA1c be used for type 2 diabetes diagnosis in the young? - DiabetesontheNet
![HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study - The Lancet HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study - The Lancet](https://www.thelancet.com/cms/attachment/2001012388/2003804835/gr1.jpg)
HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study - The Lancet
![Assessment of the effect of the COVID-19 pandemic on UK HbA1c testing: implications for diabetes management and diagnosis | Journal of Clinical Pathology Assessment of the effect of the COVID-19 pandemic on UK HbA1c testing: implications for diabetes management and diagnosis | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/76/3/177/F3.large.jpg)